Authors: JOSHI R ARORA V DESJARDINS JP ROBINSON D HIMMELSTEIN KJ IVERSEN PL

Citation: R. Joshi et al., IN-VIVO PROPERTIES OF AN IN-SITU FORMING GEL FOR PARENTERAL DELIVERY OF MACROMOLECULAR DRUGS, Pharmaceutical research, 15(8), 1998, pp. 1189-1195

Authors: DESJARDINS JP BEARD SE MAPOLES JE GEE P THOMPSON JA

Citation: Jp. Desjardins et al., TRANSCRIPTIONAL ACTIVITY OF QUINONE METHIDES DERIVED FROM THE TUMOR PROMOTER BUTYLATED HYDROXYTOLUENE IN HEPG2 CELLS, Cancer letters, 131(2), 1998, pp. 201-207

Authors: DESJARDINS JP SPROAT BS BEIJER B BLASCHKE M DUNKEL M GERDES W LUDWIG J REITHER V RUPP T IVERSEN PL

Citation: Jp. Desjardins et al., PHARMACOKINETICS OF A SYNTHETIC, CHEMICALLY-MODIFIED HAMMERHEAD RIBOZYME AGAINST THE RAT CYTOCHROME-P-450 3A2 MESSENGER-RNA AFTER SINGLE INTRAVENOUS INJECTIONS, The Journal of pharmacology and experimental therapeutics, 278(3), 1996, pp. 1419-1427

Authors: DESJARDINS JP IVERSEN PL

Citation: Jp. Desjardins et Pl. Iversen, INHIBITION OF THE RAT CYTOCHROME-P450 3A2 BY AN ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE IN-VIVO, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1608-1613